Home / Companies / Centessa Pharmaceuticals Plc / 12 Jun 2026
Centessa Pharmaceuticals Plc: meeting of 12 Jun 2026
Votes reported on Form N-PX, item by item
63 Form N-PX filers reported votes at the Centessa Pharmaceuticals Plc meeting of 12 Jun 2026. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 87.3% of reported votes for; 16 filers withheld from or voted against at least one nominee.
165 vote records from 44 filers. 1 of the 44 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
14 vote records from 12 filers. 0 of the 11 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
165 vote records from 44 filers. 1 of the 44 filers that marked the item either way voted against management.
EXTRAORDINARY TRANSACTIONSIssuer
EXTRAORDINARY TRANSACTIONS: management items
Management items in this category are shown together; filers word and number them differently.
74 vote records from 50 filers. 0 of the 50 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
52 vote records from 43 filers. 1 of the 43 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
97 vote records from 42 filers. 1 of the 42 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
84 vote records from 10 filers. 0 of the 10 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| BlackRock and iShares | For | For | For |
| Fidelity | For | No report | For |
| State Street and SPDR | For | No report | For |
| American Century | For | No report | For |
| Invesco | For | No report | For |
| Equitable | For | For | For |
| ProShares and ProFunds | For | No report | For |
| Jackson National funds | For | No report | For |
| T. Rowe Price | For | No report | For |
| First Trust | For | No report | For |
| Russell Investments | For | No report | For |
| Principal | For | No report | For |
| Capital Group and American Funds | For | No report | For |
| Pacific Life funds | For | No report | For |
| Federated Hermes | For | No report | For |
| Virtus | For | No report | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Centessa Pharmaceuticals Plc meeting?
63 Form N-PX filers reported votes at the meeting of 12 Jun 2026. On say-on-pay, 0 of 11 voted against management (0.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Centessa Pharmaceuticals Plc on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Centessa Pharmaceuticals Plc
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Centessa Pharmaceuticals Plc with a meeting date within three days of 12 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.